Fatty Acid Oxidation Disorders (FAODs) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

 Fatty Acid Oxidation Disorders (FAODs) are a group of inherited metabolic conditions that result in an accumulation of fatty acids and a decrease in cell energy metabolism. Each fatty acid oxidation disorder is caused by a specific enzyme defect in the fatty acid metabolic pathway and has an impact on dietary and stored fat utilisation. The presentation of a FAOD varies depending on the disorder, but common elements may be observed and ultimately require similar treatment. Initial presentations of the FAODs in the neonatal period with severe symptoms include cardiomyopathy, while liver dysfunction and hypoketotic hypoglycemia are common during infancy and childhood. Fatty Acid Oxidation Disorders (FAODs) are all inherited in an autosomal recessive manner. Patients will have inherited two copies of a FAOD with a mutation or variant in the DNA sequence. Each pregnancy will have a one-in-four chance of a child being affected, a one-in-two chance of being an unaffected carrier, and a one-in-four chance of being unaffected and not a carrier.

·       According to the study, there is an estimated collective incidence of 0.85 to 1.12 cases in every 5,000 to 10,000 births, although the individual prevalence varies significantly. MCAD is the most common of the fatty acid oxidation disorders, affecting one in every 10,000 to 20,000 births. LCHAD and VLCAD are rare disorders that affect one in every 100,000 births. There appears to be a mild form of SCAD deficiency that is quite common, but the clinical significance of this condition is unknown.

Thelansis’s “Fatty Acid Oxidation Disorders (FAODs) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fatty Acid Oxidation Disorders (FAODs) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Fatty Acid Oxidation Disorders (FAODs) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Fatty Acid Oxidation Disorders (FAODs) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Fatty Acid Oxidation Disorders (FAODs) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032